Diagnostic Approach and Treatment for Diffuse Infiltrates on Chest Imaging

Diagnostic Evaluation

High-resolution CT (HRCT) is essential for characterizing diffuse infiltrates, revealing pathological findings in approximately 50% of patients with normal chest radiographs, according to the American College of Radiology 1, 2
HRCT findings can help distinguish between different etiologies, such as nodular or cavitary lesions suggesting invasive fungal infection, as recommended by the Infectious Diseases Society of America 3
Diffuse bilateral perihilar infiltrates, ground-glass opacities with peripheral sparing, cysts, and septal thickening may indicate Pneumocystis pneumonia, as suggested by the Centers for Disease Control and Prevention 1, 3
Profuse centrilobular nodules, mosaic attenuation, and air-trapping suggest hypersensitivity pneumonitis, according to the American Thoracic Society 4
Ground-glass opacities may indicate drug-related pneumonitis, as reported by the European Respiratory Society 5

Two sets of blood cultures should be obtained in all patients, as recommended by the Society of Critical Care Medicine 6
Bronchoalveolar lavage (BAL) should be performed for microbiological diagnosis, with samples sent for bacterial, fungal, and mycobacterial cultures, as suggested by the American Thoracic Society 7
Galactomannan and β-D-glucan testing for fungal infections should be performed, as recommended by the Infectious Diseases Society of America 1, 8
PCR for viral pathogens and Pneumocystis jirovecii should be performed, as suggested by the Centers for Disease Control and Prevention 9

Empiric broad-spectrum antibiotics should be initiated promptly in febrile patients, as recommended by the Infectious Diseases Society of America 1, 3
Pre-emptive treatment with mold-active systemic antifungal agents improves clinical outcome in high-risk patients with CT findings suggestive of invasive fungal disease, as suggested by the European Society of Clinical Microbiology and Infectious Diseases 1, 2
High-dose trimethoprim-sulfamethoxazole (TMP/SMX) is the first-choice treatment for Pneumocystis pneumonia, as recommended by the Centers for Disease Control and Prevention 1, 9
Adjunctive corticosteroids should be considered in moderate to severe cases of Pneumocystis pneumonia, as suggested by the Centers for Disease Control and Prevention 9
Discontinuation of the offending drug is essential for drug-related pneumonitis, as recommended by the European Respiratory Society 5
Removal of the causative antigen is the primary intervention for hypersensitivity pneumonitis, as suggested by the American Thoracic Society 4
Diuretics and optimization of cardiac function are recommended for pulmonary edema, as suggested by the European Society of Cardiology 10

A more aggressive diagnostic approach is warranted in immunocompromised patients due to higher mortality, and consider broader differential diagnoses including opportunistic infections, as recommended by the Infectious Diseases Society of America 9
Early bronchoscopy with BAL should be performed before empiric antimicrobial therapy alters diagnostic yield in immunocompromised patients, as suggested by the American Thoracic Society 9